ARKAY Therapeutics

Advancing TriGlytza, a pancreatic beta-cell centric combination product for treating Type 2 diabetes and Covid

  • Stage Product In Development
  • Industry Other
  • Location East Windsor, NJ, USA
  • Currency USD
  • Founded August 2014
  • Employees 1
  • Incorporation Type LLC
  • Website arkaytherapeutics.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free